Two members of Florida’s delegation to the U.S. Property of Representatives introduced a bill on Thursday that would expand analysis into the medicinal use of marijuana. The measure, titled the Expanding Cannabis Study and Data Act, was filed by Democratic Rep. Donna Shalala and her Republican colleague Rep. Matt Gaetz has signed on as a co-sponsor.
If passed, the bill “would create a national cannabis analysis agenda, direct the U.S. Division of Wellness and Human Services to gather information on the wellness impacts of cannabis, establish a National Institutes of Wellness ‘Centers of Excellence’ analysis designation, and reclassify cannabis as a Schedule III controlled substance,” according to Shalala’s workplace.
“For years now, states across the nation have been liberalizing their cannabis laws with no producing corresponding investments in establishing a much better scientific understanding of the quick and extended-term added benefits and effects of cannabis on human wellness,” mentioned Shalala. “By rescheduling cannabis and directing our national analysis infrastructure to study and gather information on how it impacts wellness outcomes, we are not only bringing federal cannabis policy into the 21st century, but we’re also guaranteeing that we do so safely.”
Bill Would Streamline Cannabis Study
“This bipartisan and bicameral legislation will boost, expedite, and streamline cannabis analysis: by rescheduling cannabis to Schedule III, this bill will lessen the conflict among states and the federal government, and by designating ‘Centers of Excellence in Cannabis Study,’ it will support unlock cures for America’s most vulnerable populations,” mentioned Gaetz.
Florida state Agricultural Commissioner Nikki Fried, who campaigned for workplace on a platform that integrated cannabis reform, applauded the action by the state’s federal lawmakers.
“On behalf of the hundreds of thousands of healthcare marijuana sufferers in Florida, I thank Congresswoman Shalala and Congressman Gaetz for their bipartisan leadership in Congress to additional crucial cannabis analysis,” mentioned Fried. “Federal cannabis policy will have to be changed to much better present secure and compassionate remedy solutions for these in need to have, and the Expanding Cannabis Study and Data Act is a welcome step forward.”
A statement from Shalala’s workplace insisted that the bill is essential.
“Currently, 11 states and the District of Columbia have legalized adult cannabis use, although 33 states have legalized healthcare cannabis use. Even so, the Drug Enforcement Administration continues to classify cannabis as a Schedule I controlled substance with no healthcare advantage,” Shalala’s workplace noted. “The Expand Cannabis Study and Data Act would enable for a dramatic expansion in analysis about the wellness added benefits and public security impacts of cannabis use.”
The Expanding Cannabis Study and Data Act has also been co-sponsored by Democratic Rep. Barbara Lee of California. The bill has been referred to the Property Power and Commerce Committee and the Property Judiciary Committee for consideration.